Im, S., Sohn, J., Tripathy, D., Chow, L., Lee, K. S., Jung, K. H., Babu, G., Im, Y., El Saghir, N., Liu, M., Diaz-Padilla, I., Alam, J., Kong, O., Miller, M., & Lu, Y. (n.d.). 39ORibociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095506764.0x000032